We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Review Panel Annual Report 2017 - a panel that performs statutory and non-statutory reviews of proposals, decisions and provisional decisions taken by MHRA.
Annual report of the Human Medicines Regulations 2012 Advisory Bodies - the Commission on Human Medicines (CHM) and the British Pharmacopoeia Commission
This plan outlines the Agency’s strategic direction over the next five years, including how we ensure a smooth EU exit under any scenario.
Business expenses incurred by Medicines and Healthcare products Regulatory Agency (MHRA) board members between July to September 2016 (quarter 2).
Business expenses incurred by Medicines and Healthcare products Regulatory Agency (MHRA) board members between April and June 2017 (quarter 1).
Business expenses incurred by Medicines and Healthcare products Regulatory Agency (MHRA) board members between October and December 2017 (quarter 3).
Business expenses incurred by Medicines and Healthcare products Regulatory Agency (MHRA) board members between October and December 2017 (quarter 2).
Business expenses incurred by Medicines and Healthcare products Regulatory Agency (MHRA) board members between January to March 2017 (quarter 4).
Business expenses incurred by Medicines and Healthcare products Regulatory Agency (MHRA) board members between October and December 2016 (quarter 3).
MHRA transactions over £500 made using the government procurement card (GPC).
MHRA has committed to being more transparent with the public about when, how and why we use animals.
Review Panel Annual Report 2016 - a panel that performs statutory and non-statutory reviews of proposals, decisions and provisional decisions taken by the MHRA.
Advisory Board on the Registration of Homeopathic Products and Herbal Medicines Advisory Committee Annual Reports 2016, along with a record of members' interests in the pharmaceutical industry.
This document contains the following information: MHRA annual report and accounts 2016 to 2017
Information on Medicines and Healthcare products Regulatory Agency spending over £25,000.
Survey of Medicines and Healthcare products Regulatory Agency staff taken in October 2016
Business expenses incurred by Medicines and Healthcare products Regulatory Agency (MHRA) board members between April and June 2016 (quarter 1).
Business expenses incurred by Medicines and Healthcare products Regulatory Agency (MHRA) board members between April and June 2015 (quarter 1).
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab).